Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.

Salinas, Claudia A; Koopmeiners, Joseph S; Kwon, Erika M; FitzGerald, Liesel; Lin, Daniel W; Ostrander, Elaine A; Feng, Ziding; Stanford, Janet L

Salinas, Claudia A; Koopmeiners, Joseph S; Kwon, Erika M; FitzGerald, Liesel; Lin, Daniel W; Ostrander, Elaine A; Feng, Ziding; Stanford, Janet L.

Affiliation

Salinas CA; Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

Prostate ; 69(4): 363-72, 2009 Mar 01.

Article in En | MEDLINE | ID: mdl-19058137

Subject(s)

Chromosomes, Human, Pair 17/genetics; Chromosomes, Human, Pair 8/genetics; Genetic Predisposition to Disease/genetics; Polymorphism, Single Nucleotide/genetics; Prostatic Neoplasms/genetics; Adult; Aged; Case-Control Studies; Genotype; Humans; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; ROC Curve; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Chromosomes, Human, Pair 8 / Chromosomes, Human, Pair 17 / Genetic Predisposition to Disease / Polymorphism, Single Nucleotide Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Prostate Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google